(Q38124734)

29 August 2017

Dilated cardiomyopathy update: infectious-immune theory revisited (English)

1 reference

29 August 2017

dilated cardiomyopathy

1 reference

Chuichi Kawai

1

1 reference

PubMed ID

23892949

29 August 2017

Akira Matsumori

series ordinal

2

1 reference

29 August 2017

1 November 2013

1 reference

29 August 2017

Heart Failure Reviews

1 reference

29 August 2017

18

1 reference

29 August 2017

6

1 reference

29 August 2017

703-714

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-013-9401-z

29 August 2017

0 references

cites work

From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

The scientific challenge of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Infectious diseases. Hard-won advances spark excitement about hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Dilated cardiomyopathy associated with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Hepatitis C virus infection and cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Myocarditis and heart failure associated with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Assessment of cardiac involvement of hepatitis C virus; tissue Doppler imaging and NTproBNP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

B70 antigen is a second ligand for CTLA-4 and CD28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Gene expression of cardiac mast cell chymase and tryptase in a murine model of heart failure caused by viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

21 January 2018

Update on myocarditis

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Usefulness of immunosuppression for giant cell myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Giant cell myocarditis. Diagnosis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Cyclophilin A affects inflammation, virus elimination and myocardial fibrosis in coxsackievirus B3-induced myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Protective role for interferon-beta in coxsackievirus B3 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Lessons from human arteries: how to design a gene therapy strategy for treatment of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Altered effects of angiotensin ii type 1 and type 2 receptor blockers on cardiac norepinephrine release and inotropic responses during cardiac sympathetic nerve stimulation in aorto-caval shunt rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Long-term follow up of initial clinical cases with NF-kappaB decoy oligodeoxynucleotide transfection at the site of coronary stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

An initial case of suppressed restenosis with nuclear factor-kappa B decoy transfection after percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Applications of nucleic acid drugs for organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Late thrombosis a concern with drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Oxygen-derived free radicals in postischemic tissue injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Gamma-globulin treatment of acute myocarditis in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-013-9401-Z

Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up

21 January 2018

1 reference

12 December 2020

Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice

1 reference

12 December 2020

Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution

1 reference

12 December 2020

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

12 December 2020

cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats

1 reference

12 December 2020

B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells

1 reference

12 December 2020

Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy

1 reference

12 December 2020

Nuclear factor-kappaB decoy: infiltrating the heart of the matter in inflammatory heart disease

1 reference

12 December 2020

The biomarker N-terminal pro-brain natriuretic peptide and liver diseases

1 reference

12 December 2020

Initial clinical cases of the use of a NF-kappaB decoy at the site of coronary stenting for the prevention of restenosis.

1 reference

12 December 2020

In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis

1 reference

12 December 2020

Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study

1 reference

12 December 2020

Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy

1 reference

12 December 2020

Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease

1 reference

12 December 2020

ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consort

1 reference

12 December 2020

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

12 December 2020

Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy

1 reference

12 December 2020

Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro

1 reference

12 December 2020

10.1007/S10741-013-9401-Z

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23892949